Comprehensive Serum Lipidomics for Detecting Incipient Dementia in Parkinson’s Disease

Abstract

While a number of methods are available for analyzing lipids, unbiased untargeted lipidomics with high coverage remains a challenge. In this work, we report a study of isotopestandard-assisted liquid chromatography mass spectrometry lipidomics of serum for biomarker discovery. We focus on Parkinson's disease (PD), a neurodegenerative disorder that often progresses to dementia. Currently, the diagnosis of PD is purely clinical and there is limited ability to predict which PD patients will transition to dementia, hampering early interventions. We studied serum samples from healthy controls and PD patients with no clinical signs of dementia. A follow-up 3 years later revealed that a subset of PD patients had transitioned to dementia. Using the baseline samples, we constructed two biomarker panels to differentiate (1) PD patients from healthy controls and (2) PD patients that remained cognitively stable from PD patients with incipient dementia (diagnosed 3 years after sample collection). The proposed biomarker panels displayed excellent performance and may be useful for detecting prodromal PD dementia, allowing early interventions and prevention efforts. The biochemistry of significantly changed lipids is also discussed within the current knowledge of neurological pathologies. Our results are promising and future work using a larger cohort of samples is warranted.

Contaminating transfection complexes can masquerade as small extracellular vesicles and impair their delivery of RNA

“…The obtained intensity ratios were filtered by relative standard deviation (RSD) of quality control experimental replicates (RSD ≤30%). Noninformative features (i.e., internal standards and features with near‐constant values between the groups determined by low RSD) were also removed before auto‐scaling, normalization to the median value and statistical analysis employing MetaboAnalyst 5.0 (Zardini Buzatto et al., 2021; Zardini Buzatto et al., 2021).…”

Liquid chromatography coupled to high-resolution mass spectrometry metabolomics: A useful tool for investigating tumor secretome based on a three-dimensional co-culture model

“…CSH (charged surface hybrid) particles were designed to enable sample loading and improve peak symmetry when using low ionic strength mobile phases, as instructed by the manufacturer. Reversed-phase columns, such as the chosen CSH C18, are broadly used for metabolomics investigation in different matrices such as plasma [ 20 ], serum [ 28 ], urine [ 29 ], tissue [ 30 ], and cell cultures [ 31 ], as chromatographic columns of this type generally result in the detection of more features [ 32 ]. The ERM obtained after the co-cultivation of both cell types was investigated.…”

Lipidomics of Bioactive Lipids in Alzheimer’s and Parkinson’s Diseases: Where Are We?

“…In addition, untargeted lipidome assessments were utilized to detect incipient dementia in PD. Lipidome analysis by isotope-standard-assisted liquid chromatography of PD patients’ serum revealed that an association with patients transitioning to the development of dementia could be characterized by a 5-lipid biomarker panel [ 97 ].…”